Monday September 24, 2018 07:41

Heathcare Press Release : 24 May 2018

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Heathcare—24 May 18

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral Heathcare—24 May 18

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation